Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial

Nicolas van Mieghem; M Unverdorben; M Valgimigli; R Mehran; Eric Boersma; U Baber; C Hengstenberg; MG Shi; C Chen; S Saito; R Veltkamp; P Vranckx; GD Dangas

doi:10.1016/j.ahj.2018.07.006

Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial

Nicolas van Mieghem, M Unverdorben, M Valgimigli, R Mehran, Eric Boersma, U Baber, C Hengstenberg, MG Shi, C Chen, S Saito, R Veltkamp, P Vranckx, GD Dangas

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

60 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	63-69
Number of pages	7
Journal	American Heart Journal
Volume	205
DOIs	https://doi.org/10.1016/j.ahj.2018.07.006
Publication status	Published - 2018

Research programs

EMC COEUR-09

Access to Document

10.1016/j.ahj.2018.07.006

http://hdl.handle.net/1765/110031

Cite this

van Mieghem, N., Unverdorben, M., Valgimigli, M., Mehran, R., Boersma, E., Baber, U., Hengstenberg, C., Shi, MG., Chen, C., Saito, S., Veltkamp, R., Vranckx, P., & Dangas, GD. (2018). Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. American Heart Journal, 205, 63-69. https://doi.org/10.1016/j.ahj.2018.07.006

@article{60c2da8cef2f45498cc0cb4bf0f95b6f,

title = "Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial",

author = "{van Mieghem}, Nicolas and M Unverdorben and M Valgimigli and R Mehran and Eric Boersma and U Baber and C Hengstenberg and MG Shi and C Chen and S Saito and R Veltkamp and P Vranckx and GD Dangas",

year = "2018",

doi = "10.1016/j.ahj.2018.07.006",

language = "Undefined/Unknown",

volume = "205",

pages = "63--69",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

}

van Mieghem, N, Unverdorben, M, Valgimigli, M, Mehran, R, Boersma, E, Baber, U, Hengstenberg, C, Shi, MG, Chen, C, Saito, S, Veltkamp, R, Vranckx, P & Dangas, GD 2018, 'Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial', American Heart Journal, vol. 205, pp. 63-69. https://doi.org/10.1016/j.ahj.2018.07.006

Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. / van Mieghem, Nicolas; Unverdorben, M; Valgimigli, M et al.
In: American Heart Journal, Vol. 205, 2018, p. 63-69.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial

AU - van Mieghem, Nicolas

AU - Unverdorben, M

AU - Valgimigli, M

AU - Mehran, R

AU - Boersma, Eric

AU - Baber, U

AU - Hengstenberg, C

AU - Shi, MG

AU - Chen, C

AU - Saito, S

AU - Veltkamp, R

AU - Vranckx, P

AU - Dangas, GD

PY - 2018

Y1 - 2018

U2 - 10.1016/j.ahj.2018.07.006

DO - 10.1016/j.ahj.2018.07.006

M3 - Article

C2 - 30172099

SN - 0002-8703

VL - 205

SP - 63

EP - 69

JO - American Heart Journal

JF - American Heart Journal

ER -